| | | | | NEW ORLEANS (Reuters) - The number of Americans drinking a daily cup of coffee is at the highest level since 2012, with demand continuing to get a boost from at-home consumption and gourmet drinks, an industry study showed on Saturday. | | |
| | | (Reuters Health) - A dash of cumin or dill might help convince high school students to load up their plate with vegetables during lunchtime in the cafeteria, a small study suggests. | | |
| | | LONDON, March 16 (Reuters) - A huge and deadly outbreak of listeria in South Africa could alter the country's approach to food-borne disease and prompt improvements in food safety standards, a leading health official said on Friday. | | |
| | | (Reuters Health) - People who have slightly elevated blood sugar that’s not high enough for a diabetes diagnosis may still have a higher risk of heart and kidney disease than individuals with normal blood sugar, a U.S. study suggests. | | |
| | | NEW YORK (Reuters) - In 2014, as Jonathan Rubin and Ian Laird considered investing in the booming U.S. cannabis industry, they hit a problem: How to value pot start-ups with little verified data on the price of the weed itself? | | |
| | | Reuters Health - Exercise training helps improve daily life for obese adults with asthma, a new study found. | | |
| | | COPENHAGEN (Reuters) - Lundbeck agreed to buy Prexton Therapeutics, a specialist in treatments for brain disorders, in a deal potentially worth $1.1 billion, the Danish drugmaker said on Friday. | | |
| | | Reuters Health - Almost half of small employers that charge tobacco users extra for their health insurance don’t offer wellness programs to help employees stop smoking, according to a recent study. | | |
| | | BOSTON (Reuters) - Massachusetts' top court on Friday opened the door for consumers to sue Merck & Co Inc and other makers of brand-name drugs over injuries blamed not on their own medications but on generic versions of their treatments made by other companies. | | |
| | | (Reuters) - The U.S. government said on Friday it will pay for certain genetic tests for Medicare-eligible patients with advanced cancer, in a bid to help match patients with the drugs most likely to provide benefit. | | |
|
| |
